Company Email Format

Biosight Ltd.

Pharmaceutical Manufacturing Airport City, Il 3 employees

Employees: 3
Contacts: 1
Emails: 1

biosight-pharma.com LinkedIn

Biosight Ltd. Overview

Headquarters: Airport City, Il
Phone Number: Available in AeroLeads
Website: biosight-pharma.com
Industry: Pharmaceutical Manufacturing
Employees: 3
Founded: 2000
Company Email: Available in AeroLeads
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

Pharmaceutical development Pro-drugs Targeted chemotherapy Biotechnology Acute myeloid leukemia (AML) myelodysplastic syndrome

About Biosight Ltd.

Biosight is a private Phase 2 clinical stage biotech company developing innovative therapeutics for hematological malignancies and disorders. Biosight’s lead product, BST-236 (aspacytarabine), is an innovative proprietary anti-metabolite which addresses unmet medical needs by enabling high-dose chemotherapy with reduced systemic toxicity. BST-236 is currently being investigated as a single agent in a Phase 2b for first-line treatment of acute myeloid leukemia (AML), following completion of a Phase 1/2a study which demonstrated tolerability with promising efficacy in the challenging population of AML patients unfit for standard of care chemotherapy. A Phase 2 study in relapsed/refractory AML and myelodysplastic syndrome (MDS) will be launched in 2020 under a collaboration agreement recently signed with the European cooperative group, GFM.